Crown Bioscience Netherlands B.V.
Leiden - Zuid-Holland
https://www.crownbio.com
Naam
Crown Bioscience Netherlands B.V.
Website
https://www.crownbio.com
Sector
Biotechnologisch speur- en ontwikkelingswerk op het gebied van medische producten en farmaceutische processen en van voeding
Werkenden
50-99 wn.
Adres
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
Postcode
2333CH
Plaatsnaam
Leiden
+1 -2 2.0 2022 2024 2025 21 24 28 2900 3d 3rs 4 5 622 7 845 858 96 98 a about accept acquired acros act actionabl adc advanc against all allow also aml analytic and animal announced anti anti-trop2 antibodies antibody antibody-drug are as at august award bas be below biomarker bioscienc biospecim biotech blog bon both br9801 breast browser browsing by cancer cell charg clas clinical collect companies company complet completed computer conjugates contact contract cookie cookies could crispr/cas9 cro crown crownlink csat customer customiz d data databases decision declin demand derived development discover discovery distributor do does driv drug ebok effectiv effort embrac emerg empower engag engineered english ensur evaluat event every excellenc excit expectation experienc explor expres factshet faster fda fierc find finest focus follow for free from full futur generated get glob global govitecan greatest guesswork harbor harness health highest highlight hkras hkras-y96d how html hu human human-relevant if imagin immuno immuno-oncology imprint improv indicates industry industry-lead information inhibitor innovation innovativ insid integrat interact io july jun ki11409b kidney know known kras kras-resistant krasg12c latest leadership leading learn lin line-derived link linkedin mak mandat marrow mas measured media method metric mia mission model modernization molecul monoclonal mor mous mu mutation named new not number off off-target offer on on-demand onco oncology operation opportunity order organization organoid other our out ov4502 overcom paca paper parp patient pdx peer-reviewed per pharmaceutical phas pictur plan platform point policy post poster preclinical predictiv preferenc preferences presented pretreated privacy progres provided publication purpos pursue q q2 q4 quality r read relentlessly relevant reliabl remember remov removed renal renal-target report represent request requirement research reserved resistanc resistant resources responsibility reviewed
Vind meer informatie over Crown Bioscience Netherlands B.V. in de interactieve versie